Stock Screener
US stocks rated by the Lician Quant model: a 1–5 rating and A+ to F grades for valuation, growth, profitability, momentum and EPS revisions, each against the stock’s sector. Filter, sort by any factor and share the URL.
76 stocks · Strong Buy or Buy · Healthcare · Valuation ≥ A-
| Stock | Quant ratingRating | ValuationVal | GrowthGrow | ProfitabilityProf | MomentumMom | EPS revisionsRev | Market capMkt cap | P/EP/E | Revenue growthRev YoY | Div. yieldYield | Short % floatShort | Next earningsEarnings |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1QTTBQ32 Bio Inc | 5.00Strong Buy | A+ | — | A+ | B | A | $206M | 6.1 | — | — | 57.9% | Nov 12 |
| 2AVAHAveanna Healthcare Holdings Inc | 4.99Strong Buy | A | A- | B+ | A | A+ | $2.9B | 10.6 | +19.5% | — | 10.2% | Nov 12 |
| 3BTSGBrightSpring Health Services, Inc. Common Stock | 4.96Strong Buy | A- | A- | B- | A | — | $11.6B | 28.4 | +22.9% | — | 12.0% | — |
| 4CONConcentra Group Holdings Parent, Inc. | 4.94Strong Buy | A- | B- | A- | A+ | B | $5.0B | 25.4 | +14.0% | 0.99% | 3.1% | Nov 5 |
| 5ASTHAstrana Health Inc | 4.93Strong Buy | A+ | A | B | C | A+ | $1.8B | 44.0 | +58.9% | — | 8.0% | Nov 5 |
| 6GMEDGlobus Medical | 4.91Strong Buy | A+ | A- | A | C | A- | $8.6B | 16.1 | +19.7% | — | 7.3% | Nov 5 |
| 7HRMYHarmony Biosciences Holdings | 4.91Strong Buy | A+ | B | A | C+ | A- | $2.2B | 12.3 | +24.3% | — | — | Nov 4 |
| 8NUTXNutex Health Inc | 4.90Strong Buy | A+ | A- | A | B- | B- | $1.4B | 7.3 | +6.9% | — | — | Nov 5 |
| 9INVAInnoviva Inc | 4.89Strong Buy | A+ | B+ | A+ | C- | A- | $1.5B | 4.3 | +18.8% | — | 10.5% | Nov 4 |
| 10PNTGPennant Group Inc | 4.85Strong Buy | A- | B+ | B+ | B+ | B+ | $1.4B | 43.7 | +37.9% | — | — | Nov 4 |
| 11ADUSAddus HomeCare Corporation | 4.84Strong Buy | A+ | B | B | B | A- | $2.3B | 21.7 | +15.9% | — | — | — |
| 12AMNAMN Healthcare Services Inc | 4.83Strong Buy | A+ | D+ | B- | A+ | A- | $1.6B | 14.9 | +24.0% | — | 10.0% | Nov 5 |
| 13MGTXMeiraGTx Holdings PLC | 4.82Strong Buy | A | A+ | A+ | D | B- | $897M | 11.4 | +948.3% | — | 17.6% | Nov 12 |
| 14RIGLRigel Pharmaceuticals Inc | 4.82Strong Buy | A+ | B+ | A+ | A | D- | $895M | 2.8 | +3.3% | — | 18.3% | Nov 5 |
| 15CRONCronos Group Inc | 4.80Strong Buy | A | A- | B+ | B+ | B- | $1.2B | 17.6 | +37.5% | — | 1.9% | Nov 5 |
| 16PDEXPro-Dex Inc | 4.79Strong Buy | A | A- | B+ | C+ | A- | $184M | 13.4 | +16.5% | — | 13.0% | — |
| 17ACADACADIA Pharmaceuticals Inc | 4.75Strong Buy | A | A- | A+ | D | B+ | $3.3B | 8.7 | +11.8% | — | 7.9% | Nov 4 |
| 18GRDNGuardian Pharmacy Services, Inc. | 4.73Strong Buy | A+ | — | B | C+ | B | $359M | 5.4 | +10.3% | — | 26.1% | Nov 5 |
| 19GSKGlaxoSmithKline PLC ADR | 4.72Strong Buy | A | B | A | C- | — | $99.3B | 13.2 | +7.4% | 3.50% | 0.4% | — |
| 20BLCOBausch + Lomb Corp | 4.70Strong Buy | A- | C | B | A- | A | $5.9B | NM | +8.9% | — | — | — |
| 21ANIPANI Pharmaceuticals Inc | 4.67Strong Buy | A+ | A | A | D | C+ | $1.6B | 14.8 | +30.9% | — | 22.7% | Nov 5 |
| 22PCRXPacira BioSciences, Inc. | 4.67Strong Buy | A | D | B+ | A | B+ | $1.4B | 98.9 | +5.7% | — | — | Nov 5 |
| 23MDTMedtronic PLC | 4.64Strong Buy | A | C+ | A- | B+ | B- | $127B | 24.2 | +9.8% | 0.00% | 10.8% | Nov 17 |
| 24WAYWaystar Holding Corp. Common Stock | 4.63Strong Buy | A- | B | A- | B | C+ | $5.5B | 40.9 | +19.2% | — | — | — |
| 25NHCNational HealthCare Corporation | 4.62Strong Buy | A | B- | A- | C+ | — | $3.2B | 23.0 | +6.9% | — | 6.1% | Nov 6 |
Showing 25 of 76
Source: Lician Quant Grades (SEC EDGAR statements, EODHD prices and estimates); short interest: FINRA; earnings dates: earnings calendar; dividend yield: EODHD fundamentals · Quant run Nov 4, 2026
Grades rank each stock against its sector peers; they are not investment advice. How the rating and grades work · Short interest · Earnings calendar